Set 1 | Set 2 | Set 3 | Set 4 | Set 5 | Set 6 | |
Clinical subtypes | ||||||
Pure motor(n = 31) | 26 (83.9%) | 6 (19.4%) | 25 (80.6%) | 25 (80.6%) | 16 (51.6%) | 9 (29%) |
Motorsensory (n = 18) | 17 (94.4%) | 13 (72.2%) | 17 (94.4%) | 15 (83.3%) | 16 (88.9%) | 14 (77.8%) |
Pure sensory (n = 2) | 2 (100%) | 1 (50%) | 2 (100%) | 2 (100%) | 1 (50%) | 2 (100%) |
Duration | ||||||
Ist wk (n = 25) | 22 (88%) | 8 (32%) | 22 (88%) | 20 (80%) | 18 (72%) | 12 (48%) |
2nd wk (n = 16) | 14 (87.5%) | 6 (37.5%) | 13 (81.3%) | 12 (75%) | 8 (50%) | 7 (43.8%) |
3rd wk (n = 10) | 9 (90%) | 6 (60%) | 9 (90%) | 10 (100%) | 7 (70%) | 6 (60%) |
Severity | ||||||
⩽3 (n = 2) | 2 (100%) | 1 (50%) | 2 (100%) | 1 (50%) | 1 (50%) | 1 (50%) |
4–6 (n = 15) | 13 (86.7%) | 5 (33.3%) | 13 (86.7%) | 11 (73.3%) | 8 (53.3%) | 7 (46.7%) |
>6 (n = 34) | 30 (88.2%) | 14 (41.2%) | 29 (85.3%) | 30 (88.2%) | 24 (70.6%) | 17 (50%) |
Outcome | ||||||
Complete (n = 11) | 9 (81.8%) | 5 (45.5%) | 9 (81.8%) | 8 (72.7%) | 8 (72.7%) | 6 (54.5%) |
Partial (n = 28) | 25 (89.3%) | 11 (39.3%) | 24 (85.7%) | 23 (82.1%) | 18 (64.3%) | 14 (50%) |
Bedridden (n = 9) | 9 (100%) | 3 (33.3%) | 9 (100%) | 9 (100%) | 6 (66.7%) | 4 (44.4%) |
Dead (n = 1) | 1 (100%) | 1 (100%) | 1 (100%) | 1 (100%) | 1 (100%) | 1 (100%) |
Set 1, Albers and colleagues2; set 2, Cornblath3; set 3, Ho and colleagues4; set 4, Dutch GBS study group5; set 5, Italian GBS study group6; set 6, Albers and Kelly.7